2.00

2.44% -0.05

Jyong Biotech Ltd (MENS)

Overview News Price History Option Chain Financials Discussions Forecast

Jyong Biotech Ltd stock is traded at $2.00, with a volume of 129.42K. It is down -2.44% in the last 24 hours and down -5.66% over the past month. Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Previous Close:

$2.05

Open:

$2.03

24h Volume:

129.42K

Relative Volume:

4.21

Market Cap:

$148.47M

Revenue:

Net Income/Loss:

$-4.67M

P/E Ratio:

-31.50

EPS:

-0.0635

Net Cash Flow:

$-3.62M

1W Performance:

-4.76%

1M Performance:

-5.66%

6M Performance:

-23.95%

1Y Performance:

-96.56%

1-Day Range:

$1.97

$2.12

1-Week Range:

$1.97

$2.18

52-Week Range:

$1.43

$63.00

Jyong Biotech Ltd Stock (MENS) Company Profile

Name

Jyong Biotech Ltd

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

MENS's Discussions on Twitter

Compare MENS vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MENS Jyong Biotech Ltd	2.00	148.47M	0	-4.67M	-3.62M	-0.0635
VRTX Vertex Pharmaceuticals Inc	508.54	128.90B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	237.85	94.96B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	800.52	82.42B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.03	53.52B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	372.06	42.09B	5.76B	514.49M	1.10B	4.4813

Jyong Biotech Ltd Stock (MENS) Latest News

Oct 02, 2026

Jyong Biotech (MENS) Shares Advance 4.93% to $2.13 as Stock Presses Toward Upper ResistanceStandard Deviation - www.dars.gov.et

Oct 02, 2026

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Throwback Trade - siam.in

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Bear Pennant - careplusvn.com

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Insider Buying Alerts - dars.gov.et

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Naked POC - dars.gov.et

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Defined Outcome ETF - dars.gov.et

Sep 09, 2026

Jyong Biotech (MENS) Jumps 7.6% to $2.28, Closing in on Resistance at $2.39Fibonacci Retracement - dars.gov.et

Sep 09, 2026

Sep 06, 2026

Jyong Biotech Ltd. Ordinary Shares (NASDAQ: MENS) Share Price, MENS Stock News, MENS Share Price & Updates - kalkine.ca

Sep 06, 2026

Sep 04, 2026

Jyong Biotech Ltd. Ordinary Shares (NASDAQ: MENS) Share Price, MENS Stock News, MENS Share Price & Updates - Kalkine

Sep 04, 2026

Sep 03, 2026

A plant-based drug developer will join a two-language online investor event Sept. 6 - Stock Titan

Sep 03, 2026

Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow - Yahoo Finance

Sep 03, 2026

Aug 20, 2026

Jyong (MENS) Move: Gains 2.88% to Reach $2.14 on the Day; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayVolume Nodes - vinanet.vn

Aug 20, 2026

Jyong (MENS) Move: Gains 2.88% to Reach $2.14 on the Day; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayBeta Neutral Pair - careplusvn.com

Aug 20, 2026

Jyong (MENS) Move: Gains 2.88% to Reach $2.14 on the Day; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayBuffered ETF - dars.gov.et

Aug 20, 2026

Aug 12, 2026

Jyong Biotech (MENS) Holds Flat at $2.1 as Shares Consolidate Between Key Support and Resistance LevelsLow Beta Factor - vinanet.vn

Aug 12, 2026

Jyong Biotech (MENS) Holds Flat at $2.1 as Shares Consolidate Between Key Support and Resistance LevelsTrading Ideas - dars.gov.et

Aug 12, 2026

Jyong Biotech (MENS) Holds Flat at $2.1 as Shares Consolidate Between Key Support and Resistance Levels - dars.gov.et

Aug 12, 2026

Aug 07, 2026

Jyong Biotech (MENS) Edges Up to $2.03, Holding a Tight Range Between Support and ResistanceDynamic Hedging - dars.gov.et

Aug 07, 2026

Jyong Biotech (MENS) Edges Up to $2.03, Holding a Tight Range Between Support and ResistanceBreakout Confirmation - dars.gov.et

Aug 07, 2026

Jyong Biotech (MENS) Edges Higher to $2.03 as Range-Bound Trading PersistsParabolic SAR - dars.gov.et

Aug 07, 2026

Aug 06, 2026

Jyong Biotech (MENS) Dips 0.98% to $2.03 as Biotech Stock Tests Range-Bound SupportIntraday Profile - vinanet.vn

Aug 06, 2026

Jul 28, 2026

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships - Macau Business

Jul 28, 2026

Jul 27, 2026

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships - The Manila Times

Jul 27, 2026